Bridging Academic & Community Cancer Care for Cellular Therapy – Dr. Bilal Abid

7 Views

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Published May 22, 2025

???? Oncology Bytes – COA 2025 | Featuring Dr. Bilal Abid
In this episode, Dr. Bilal Abid, an academic clinician scientist based in Houston, discusses one of the most pressing challenges in oncology: building equitable access to cellular therapies in community settings.
Drawing from his experience at COA 2025 and his clinical work, Dr. Abid covers:

- How community practices are preparing for bispecifics and CAR-T therapy
- The disparity in access based on ZIP code and insurance.
- Why building uniform infrastructure for cellular therapy is essential for health equity
- The "offensive triangle" model between academic centers, community oncologists, and pharma partners
- How collaboration can bring advanced therapies to all patients, not just those near large academic institutions

Dr. Abid emphasizes that as oncology moves forward, no patient should be left behind in accessing transformative treatments.

????Reach out to Dr. Bilal Abid here:
Linkedin: https://www.linkedin.com/in/m-bilal-abid-md-ms-facp-mrcp-frcp-5a23b2261/
Twitter: https://x.com/BilalAbidMD

???? Learn more at: https://oncoassist.com/
---------------------------------------------------

???? Oncology at your fingertips.
Download the ONCOassist app:
???? iOS: https://apple.co/4iuMxfS
???? Android: https://bit.ly/oncoassistonandroid
???? SUBSCRIBE to the ONCOassist Youtube Channel for more expert insights!
???? Turn on notifications so you never miss an episode.
???? FOLLOW US FOR UPDATES:
???? LinkedIn: https://bit.ly/oncoassistlinkedin
???? Twitter/X: https://bit.ly/oncoassisttwitter

#OncologyBytes #COA2025 #BilalAbid #CellularTherapy #CommunityOncology #CAR-T #CancerCareAccess #HealthEquity #Bispecifics #Oncoassist #AcademicMedicine #OncologyInnovation #Oncoalert